Letter Sequence Request |
---|
|
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017 Irrevocable Standby Letter of Credit (Redacted) Project stage: Request ML18054A0772018-03-0808 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18092A0872018-03-27027 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18087A3892018-03-28028 March 2018 Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC Project stage: Request ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018 Shine Medical Technologies, Inc. April 3, 2018 Public Meeting Project stage: Request ML18096A6882018-04-0303 April 2018 Confirmatory Action Letter (CAL) No. NRR-2011-001 Project stage: Request ML18096A4552018-04-0303 April 2018 Shine Operating License Pre-Application Meeting (Environmental Presentation Slides) Project stage: Request ML18087A3402018-04-0303 April 2018 Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18096A6892018-04-0303 April 2018 Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations Project stage: Request ML18130A5782018-05-0707 May 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18162A1362018-05-11011 May 2018, 18 June 2018 Shine Medical Technologies, Inc. May 23, 2018 Public Meeting Project stage: Request ML18138A2912018-05-16016 May 2018 Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC Project stage: Request ML18128A0342018-05-16016 May 2018 Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18156A1302018-06-0101 June 2018 Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18155A6032018-06-0707 June 2018 Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18162A1172018-06-18018 June 2018 Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report Project stage: Other ML18162A0552018-06-18018 June 2018 Shine Medical Technologies April 3, 2018 Public Meeting Summary Project stage: Meeting ML18162A1162018-06-18018 June 2018 Shine Medical Technologies Annual Financial Report Project stage: Request ML18162A1182018-06-18018 June 2018 Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report Project stage: Other ML18162A1292018-06-18018 June 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions Project stage: Other ML18162A1382018-06-18018 June 2018 May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc Project stage: Meeting ML18127B7062018-06-21021 June 2018 Closure of NRC Confirmatory Action Letter No. NRR-2011-001 Project stage: Other ML18221A4532018-06-27027 June 2018, 17 August 2018 Shine Medical Technologies, Inc. June 2018 Public Meeting Project stage: Request ML18187A2162018-07-0202 July 2018 Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML18197A0802018-07-10010 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18193A1412018-07-16016 July 2018 Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18277A1962018-07-17017 July 2018 Amendment to Standby Letter of Credit (Redacted) Project stage: Request ML18206A7262018-07-18018 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted) Project stage: Request ML18221A4542018-08-17017 August 2018 Summary of Meeting with Shine Medical Technologies, Inc. Project stage: Meeting ML18239A2192018-08-27027 August 2018 Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility Project stage: Request ML18268A3442018-10-0202 October 2018 Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014 Project stage: Other ML18340A1712018-12-10010 December 2018 Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions Project stage: Other ML18340A2762018-12-19019 December 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements Project stage: Other ML19025A2642019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML19025A2752019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19015A3522019-02-15015 February 2019 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML19071A1852019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure Project stage: Other ML19071A1812019-03-22022 March 2019 Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary Project stage: Meeting ML19071A1792019-03-22022 March 2019 Shine Medical Technologies, Inc. January 31, 2019 Public Meeting Project stage: Request ML19071A1802019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance 2018-06-18
[Table View] |
|
---|
Category:Letter
MONTHYEARML24270A2422024-09-26026 September 2024 OIG Case 21-012 Response to OIG Letter Dated September 4, 2024 Regarding NRC-OIG Decision to Carry Over Case 21-012 Investigation Findings to Report for Case 21-016 ML24235A5122024-08-22022 August 2024 NRC-OIG_Failure_8-22-24_final ML24220A0532024-08-12012 August 2024 Response to Dr. Slaughter on Final Denial of Claims ML24197A1112024-07-10010 July 2024 Letter Regarding Denying Reimbursement for Service the NRC Did Not Perform in a Satisfactory Manner ML24151A6482024-06-0303 June 2024 Changes in Reactor Decommissioning Branch Project Management Assignments for Some Decommissioning Facilities ML24134A2072024-05-13013 May 2024 Aerotest - NRC Acknowledgment Letter for CFH Program NOV EA-23-118 ML24108A0762024-05-0606 May 2024 Missing Documents on Agencywide Documents Access and Management System ML24085A2662024-03-20020 March 2024 Requesting a Comprehensive Congressional Review Be Conducted of the NRCs Performance Concerning Their Actions Associated with Aerotest Operations Inc (AO) as Outlined in NRC-OIG Investigation 021-012 and 021-016 ML24073A2182024-03-18018 March 2024 Inc. - NRC Inspection Report 050 00228/2023001, Response to Disputed Minor Violation ML24061A0232024-02-27027 February 2024 EA-23-118, Violation 050-00228/203-001-00lA ML24057A0102024-02-21021 February 2024 Inc - Minor Violation (TS 12.6.1) 050-00228/2023-001 and NRCs Definition of Annually ML24057A0112024-02-21021 February 2024 Inc - Response to Notice of Violation No 05000228/2020201 IR 05000228/20202012024-02-20020 February 2024 NRC Inspection Report 05000228/2020201, and Disputed Cited Violation Closed ML24054A0542024-02-16016 February 2024 Missing Documents on Agencywide Documents Access and Management System (ADAMS) ML24039A0382024-02-0808 February 2024 NRC Inspection Report 050-00228/2023-001 (Revised), and Notice of Violation IR 05000228/20230012024-02-0505 February 2024 NRC Inspection Report 050-00228/2023-001, Disputed Cited Violation and Minor Violation Revised, EA-23-118 ML24025A1672024-02-0505 February 2024 NRC Inspection Report 050-00228/2023-001, Disputed Cited Violation and Minor Violation Revised, EA-23-118 ML24026A0572024-01-23023 January 2024 EA-23-118 - Missing NRCs 90-day Written Response to Aerotest Operations, Inc., Response to NRC Inspection Report 05000228/2023001 and Dispute of Violation ML24011A2242023-11-10010 November 2023 Letter Informing That New Information Is Available to Show Inadequate Oversight by NRC Caused Damage to Other Non-Power Nuclear Facilities ML23279A1062023-10-0202 October 2023 Response to Violation 05000228/2023001-001B ML23255A0362023-09-0909 September 2023 Response to Inspection Report 050-00228/2023-001 ML23255A0342023-09-0909 September 2023 Response to Violation 050-00228/2023-001-00lA ML23219A1882023-08-24024 August 2023 NRC Inspection Report 05000228/2023001, and Notice of Violation ML23187A0582023-07-0101 July 2023 July 1, 2022 Thru June 30, 2023 Summary of Changes, Tests, and Experiments ML23187A0562023-07-0101 July 2023 Radiation Safety Officer Change Update ML23157A0662023-05-24024 May 2023 Letter from David Slaughter, Aerotest Operations, Inc. Inadequate Oversight of Non-Power Reactor OIG Case No. 21-012 and Requested Payment for Damages Caused by the Nrc'S Inadequate Oversight ML22361A1022023-02-24024 February 2023 Reactor Decommissioning Branch Project Management Changes for Some Decommissioning Facilities and Establishment of Backup Project Manager for All Decommissioning Facilities ML22340A0062022-11-16016 November 2022 Reference Documents from Decommissioning Plan ML22215A1522022-07-21021 July 2022 Aerotest Radiography and Research Reactor - AO RAI Responses for Decommissioning Plan ML22187A0852022-07-0101 July 2022 Inc - July 1, 2021 Thru June 30, 2022 Summary of Changes, Tests, and Experiments ML22152A2522022-06-28028 June 2022 Request for Additional Information on Review of Request for Amendment to Approve Decommissioning Plan, Arrr (License No. R-98, Docket No. 50-228) ML22060A2602022-03-21021 March 2022 Change in NRC Staff Project Management Responsibility for the Aerotest Radiography and Research Reactor ML22040A1992022-03-0909 March 2022 Examination Confirmation Letter No. 50-288/OL-22-03, Reed College ML22025A2002022-01-20020 January 2022 Amendment to AO Decommissioning Plan Submittal Letter Dated July 20, 2021, Agencywide Documents Access, and Management System (ADAMS) Accession No. ML21230A304 ML21307A3242022-01-12012 January 2022 Request for Supplemental Information for Decommissioning Plan, Arrr (License R-98, Docket 50-228) ML21344A0332022-01-0303 January 2022 Aerotest Letter from the Chief Financial Officer Regarding Additional Information for the Fees Assessed Under to Aerotest Operations, Inc. (Aerotest) within Invoice Number Lfb 22-0346 ML21361A0472021-12-21021 December 2021 Response to December 6, 2021 NRC Pol Issuance; the Licensee and Its Reactor Safeguard Committee Request a Reasonable Opportunity to Review and Address Short Comings of the Draft Licensee and Technical Specifications Along with the Draft Sa ML21242A4632021-12-0606 December 2021 Issuance of License Amendment No. 6 to Facility Operating License No. R-98 for the Aerotest Radiography and Research Reactor with Partial Denial of Amendment Request ML21307A1252021-10-28028 October 2021 Letter Regarding Charges Billed ML21230A3042021-07-20020 July 2021 Decommissioning Plan Submittal (Redacted) ML21209A5192021-07-20020 July 2021 Aerotest Radiography and Research Reactor, Response to NRC Letter Dated July 12, 2021 (ML21188A391) ML21147A3732021-07-19019 July 2021 Correction of Letters Regarding Closure of Confirmatory Action Letter No. NRR-04-003 and Review of Physical Security Plan ML21188A3912021-07-12012 July 2021 Inc. - Revised Completion Date Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License ML21193A0892021-07-0101 July 2021 Emergency Plan (Redacted) ML21188A2162021-07-0101 July 2021 July 1, 2020 Through June 30, 2021 Summary of Changes, Tests, and Experiments ML21181A1232021-06-22022 June 2021 License and TS Amendments ML21147A0602021-05-19019 May 2021 Response to RAI 28 and 29 ML21056A3172021-04-30030 April 2021 CFO Response to Aerotest November 11 2020 Letter ML21126A1502021-04-28028 April 2021 License and TS Amendments ML21098A1572021-03-31031 March 2021 Response to RAI CFH Training and Requalification Program- 3/30/21 2024-09-26
[Table view] |
Text
AEROTEST OPERATIONS, INC.
3455 FOSTORIA WAY* SAN RAMON, CA 94583 * (925) 866-1212
- FAX (925) 866-1716 July 10, 2018 ATTENTION: Document Control Desk U.S. Nuclear Regulatory Commission White Flint North 11555 Rockville Pike Rockville, MD 20852-2738 AEROTEST RADIOGRAPHY AND RESEARCH REACTOR DOCKET NO. 50-228/LICENSE NO. R-98.
SUBJECT:
AEROTEST OPERATIONS, INC. - IRREVOCABLE STANDBY LETTER OF CREDIT FOR THE AEROTEST RADIOGRAPHY AND RESEARCH REACTOR Ladies and Gentlemen:
I formally request 120 day extension beyond the initial response deadline given for responding to NRC Letter (ML18054A077) dated March 8, 2018. The letter identifies two apparent substantive differences between Aerotest's irrevocable standby letter of credit, dated July 14, 2017, and RG 1.159.and requests Aerotest to explain how it will conform to RG 1.159. The proposed changes by Aerotest were submitted to Bank of the West (Bo W) for their acceptance and corrective action.
Aerotest's recently received alternative text for the LOC proposed by BoW; I determined that their response concerning insolvency notification to the applicant and beneficiary was not adequate. A follow up revision (referencing RG 1.159 Appendix A-5) was resubmitted to BoW and is currently under review.
The suggested second point to be incorporated into our letter of credit is about notification of the viability ofBoW. It is understood that the applicant or beneficiary will not benefit (relocate or draw funds) from BoW's insolvency/bankruptcy. For improved clarification of timely notification, the word "immediate" is being replaced with the phase "within 30 days". (The word "immediate" is defined in the Dodd-Frank Act as "within 30 days")
Possible language for Point 2: "We shall give notice within 30 days to the applicant and the US NRC of any notice received or action filed alleging (1) the insolvency or bankruptcy of the financial institution or (2) any violations of regulatory requirements that could result in suspension or revocation of the bank's charter or license to do business. We also shall give notice if we, for any reason, become unable to fulfill our obligation under the letter of credit."
I am still awaiting BoW acceptance or alternate language. In the event they cannot accept the terms as needed, a second banking institution has already agreed to the terms and is preparing a LOC if an institutional change is necessary.
Should you have any questions or require additional information regarding this submission, please contact AO President David M. Slaughter, Ph.D. at (801) 631 5919 or dmsraven@gmail.com I declare under penalty of perjury that the statements above are correct and truthful.
Sincet~ly yours,
'\"'-
~:) ....
- ---
David M.'Slaughter, Ph.D.
President and Reactor Admin.
Aerotest Operations, Inc.